Department: Centre for Cutaneous and Cell Biology, Blizard Institute
Salary: £22,212 - 26,346 per annum (Grade 2)
Date posted: 12-Jan-2021
Closing date: 28-Feb-2021
About the Role
Senotherapy is an exciting, emerging anti-cancer concept that offers the potential to maximise therapeutic efficiency and patient outcome. Senotherapy harnesses a new class of small molecules, called senolytics, to selectively kill senescent cells. They can be used as a follow-on to existing regimes that trigger tumour cell senescence or combined with targeted pro-senescence therapies.
Using high-throughput screening approaches, we have identified compounds that can selectively kill senescent cells.
This project aims to perform further pre-clinical validation of these compounds utilising established 2D and 3D in vitro models.
To achieve this we will utilise a spectrum of cutting-edge technologies including high-throughput high content imaging and compound screening.
A graduate potentially with a MSc/MRes in a relevant area (e.g. Biology, Cancer, Drug Discovery). A background in senescence, cancer, high-throughput cell culture and high content analysis is highly desirable.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities including an on-site nursery at the Mile End campus.
The post is based at the Whitechapel Campus in London. It is full time and fixed-term for 1 year, with an expected start date of 1 March 2021. The starting salary will be grade 2, in the range of £22,212 - 26,346 per annum.
This ambitious project will be based in Cleo Bishop’s group. Interested applicants are encouraged to contact us prior to the deadline. We believe we are poised to make significant contributions to this exciting and emerging field, and are therefore seeking a highly motivated and enthusiastic candidate with an interest in senescence to join our team.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
Informal enquiries should be addressed to Cleo Bishop (email@example.com)
To apply for the role, please click the ‘apply’ button below.
The closing date for applications is 28th February 2021.
Interviews are expected to be held shortly thereafter.
The School of Medicine and Athena SWAN Charter for Women in Science.
The School of Medicine holds a Silver Athena SWAN Award. We are committed to the equality of opportunities and to advancing women’s careers. We have policies to support staff returning from long-term absence, for flexible arrangements for staff with parental responsibilities and for childcare support. As part of the School’s commitment to the Athena SWAN principles we strongly encourage applications from women.
Valuing Diversity & Committed to Equality